Αρχειοθήκη ιστολογίου

Τρίτη 20 Ιουνίου 2017

A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies

Conditions:   Acute Lymphocytic Leukemia;   Chronic Lymphocytic Leukemia;   Lymphoma Intervention:   Combination Product: Drugs and anti-CD19 CAR transduced T cells Sponsors:   Second Affiliated Hospital of Guangzhou Medical University;   Shenzhen Institute for Innovation and Translational Medicine;   Guangzhou First People's Hospital;   First People's Hospital of Foshan;   Dongguan People's Hospital;   The First Affiliated Hospital of Guangdong Pharmaceu tical University Recruiting - verified June 2017 (Source: ClinicalTrials.gov)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2sSYRkj
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader